Global Automated CPR Devices Market Market: Key Developments
In November 2020, ZOLL Medical Corporation, a US-based manufacturer of critical care devices and systems partnered with BewellConnect, the e-health subsidiary of Visiomed Group, a developer of health products and services, for Resarch & Development of a mobile health solution that integrates ZOLL RescueNet AmbulancePad with BewellConnect VisioCheck for the French market.
In October 2022, LUCAS, annpunced the launch of the battery-powered device's for automated CPR. The LUCAS device eliminates the need to switch out CPR providers every two minutes and removes the effects of fatigue, individual variances, or psychological factors. Additionally, LUCAS offers superior and safer chest compressions in situations like patient movement and transportation, extended CPR, or the cath lab.
In February 2022, CPR Therapeutics Inc., a medical device company developing the next-generation system for cardiopulmonary resuscitation, announced that the company has received a U.S. patent for another component of technology that underlies its multimodal cardiopulmonary resuscitation (CPR) system: “Incorporation of the Electrodes for Defibrillation into the Patient-Facing Components of automated Cardiopulmonary Resuscitation Systems”. This multimodal CPR cannot be performed by humans, and significantly increases blood flow to the heart and brain while enhancing electrical countershock.
In September 2022, CPR Therapeutics Inc., a medical device company developing the next-generation system for cardiopulmonary resuscitation, announced that it has received a US$1.6M National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) Direct-To-Phase II Small Business Innovation Research Award for its project “A Multimodal Integrated System for Improved Cardiopulmonary Resuscitation.” The project will be conducted in collaboration with The Johns Hopkins Hospital in Baltimore, MD. CPR Therapeutics is developing multimodal cardiopulmonary resuscitation (CPR), a more effective form of automated mechanical CPR. Sudden cardiac arrest is the leading cause of death in western countries and there are currently no devices more effective than manual chest compressions. Intact survival after sudden cardiac arrest is below 10% in most communities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients